AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18157674 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical steroid cream (monometasone furoate 0.1%) applied twice a day for 4 weeks
Number of subjects: 240
Study 18157674 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream applied twice a day for 4 weeks
Number of subjects: 240
Study 16421647 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 microg daily
Number of subjects: 63
Study 16421647 — intervention group
Group type: COMPARATOR
Intervention: Calcitonin 100 IU daily
Number of subjects: 63
Study 15231471 — intervention group
Group type: EXPERIMENTAL
Intervention: GE 400 ultrasound machine
Number of subjects: 49
Study 15231471 — intervention group
Group type: COMPARATOR
Intervention: SonoSite 180 Plus ultrasound machine
Number of subjects: 49
Study 10772301 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 58
Study 10772301 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 58
Study 10772301 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms suggestive of OSAS
Number of subjects: 58
Study 10772301 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnography (PSG)
Number of subjects: 58
Study 10772301 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation period
Number of subjects: 58
Study 10772301 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoidectomy alone
Number of subjects: 58
Study 9557074 — intervention group
Group type: EXPERIMENTAL
Intervention: Children from HTG families
Number of subjects: 41
Study 9557074 — intervention group
Group type: COMPARATOR
Intervention: Control children from healthy families
Number of subjects: 41
Study 8317643 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium 1 mg
Number of subjects: 200
Study 8317643 — intervention group
Group type: COMPARATOR
Intervention: Saline pretreatment
Number of subjects: 200
Study 8317643 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium pretreatment
Number of subjects: 200
Study 8317643 — intervention group
Group type: EXPERIMENTAL
Intervention: Suxamethonium
Number of subjects: 200
Study 3519879 — intervention group
Group type: EXPERIMENTAL
Intervention: melphalan and prednisone (MP)
Number of subjects: 0
Study 3519879 — intervention group
Group type: EXPERIMENTAL
Intervention: prednisone, Adriamycin, azathioprine, and vincristine (PAIV)
Number of subjects: 0
Study 3519879 — intervention group
Group type: COMPARATOR
Intervention: no therapy until relapse, then treatment with BCP
Number of subjects: 0
Study 30099128 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin for monosymptomatic NE
Number of subjects: 184
Study 30099128 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin for nonmonosymptomatic NE with overactive bladder
Number of subjects: 184
Study 30099128 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment response for NE
Number of subjects: 184
Study 30099128 — intervention group
Group type: EXPERIMENTAL
Intervention: Response to LUTS treatment
Number of subjects: 184
Study 26433217 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 10-Hz rTMS applied to the left DLPFC for 3 weeks (15 sessions, 1000 stimuli per session)
Number of subjects: 156
Study 26433217 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 156
Study 25532971 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 631
Study 25532971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 631
Study 22758791 — intervention group
Group type: EXPERIMENTAL
Intervention: Protamine zinc recombinant human insulin (PZIR) at 0.3 U/kg
Number of subjects: 10
Study 22758791 — intervention group
Group type: EXPERIMENTAL
Intervention: Protamine zinc recombinant human insulin (PZIR) at 0.5 U/kg
Number of subjects: 10
Study 22758791 — intervention group
Group type: EXPERIMENTAL
Intervention: Protamine zinc recombinant human insulin (PZIR) at 0.8 U/kg
Number of subjects: 10
Study 22758791 — intervention group
Group type: EXPERIMENTAL
Intervention: Protamine zinc recombinant human insulin (PZIR) at 0.8 U/kg at three separate sites
Number of subjects: 10
Study 20484549 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in fruits and vegetables
Number of subjects: 327
Study 20484549 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive use
Number of subjects: 327
Study 20484549 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural menopause
Number of subjects: 327
Study 20484549 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise (walking and gardening)
Number of subjects: 327
Study 20484549 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy physical activity in one's 20s
Number of subjects: 327
Study 20484549 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer in a first-degree relative
Number of subjects: 327
Study 20484549 — intervention group
Group type: EXPERIMENTAL
Intervention: History of prior benign breast lumps
Number of subjects: 327
Study 20484549 — intervention group
Group type: EXPERIMENTAL
Intervention: Numbers of BSE per year
Number of subjects: 327
Study 20484549 — intervention group
Group type: EXPERIMENTAL
Intervention: Years of education
Number of subjects: 327
Study 17921185 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept (approximately 10 mg/kg)
Number of subjects: 317
Study 17921185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study 16463820 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive craniectomy
Number of subjects: 737
Study 16463820 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 737
Study 12075267 — intervention group
Group type: EXPERIMENTAL
Intervention: QRS duration > or = 120 ms
Number of subjects: 669
Study 12075267 — intervention group
Group type: EXPERIMENTAL
Intervention: QRS duration > or = 120 ms in patients with EF <30%
Number of subjects: 669
Study 12075267 — intervention group
Group type: EXPERIMENTAL
Intervention: QRS duration > or = 120 ms in patients with EF 30% to 40%
Number of subjects: 669
Study 12075267 — intervention group
Group type: EXPERIMENTAL
Intervention: Left bundle branch block
Number of subjects: 669
Study 12075267 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolongation of QRS
Number of subjects: 669
Study 9888410 — intervention group
Group type: EXPERIMENTAL
Intervention: OTZ (70 mg/kg IV every 8 hours for 9 days)
Number of subjects: 9
Study 9888410 — intervention group
Group type: COMPARATOR
Intervention: Cirrhosis patients (compared to controls)
Number of subjects: 9
Study 7746775 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 500 micrograms (two puffs of Becloforte) with a 750 ml spacer
Number of subjects: 26
Study 7746775 — intervention group
Group type: COMPARATOR
Intervention: Inhaled beclomethasone dipropionate (BDP) 500 micrograms (two puffs of Becloforte) without a spacer
Number of subjects: 26
Study 1981319 — intervention group
Group type: EXPERIMENTAL
Intervention: UK-52,046 (0.4 microgram kg‐1 i.v.)
Number of subjects: 6
Study 1981319 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (0.25 mg i.v.)
Number of subjects: 6
Study 1981319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 1981319 — intervention group
Group type: EXPERIMENTAL
Intervention: UK-52,046
Number of subjects: 6
Study 6102230 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine 0.5%
Number of subjects: 53
Study 6102230 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 53
Study 30786254 — intervention group
Group type: EXPERIMENTAL
Intervention: Milking of the umbilical cord (4 times before clamping)
Number of subjects: 204
Study 30786254 — intervention group
Group type: COMPARATOR
Intervention: Delayed clamping (60 seconds)
Number of subjects: 204
Study 29037638 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Pilates exercise (n = 17)
Number of subjects: 33
Study 29037638 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise (n = 16)
Number of subjects: 33
Study 26047385 — intervention group
Group type: EXPERIMENTAL
Intervention: PHEMA (poly(2-hydroxyethylmethacrylate))
Number of subjects: 18
Study 26047385 — intervention group
Group type: COMPARATOR
Intervention: Histoacryl/lipiodol mixture
Number of subjects: 18
Study 23681930 — intervention group
Group type: EXPERIMENTAL
Intervention: Ataluren
Number of subjects: 57
Study 23681930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 21510864 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fortification breakfast cereal
Number of subjects: 73
Study 21510864 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate fortification breakfast cereal
Number of subjects: 73
Study 21510864 — intervention group
Group type: EXPERIMENTAL
Intervention: High fortification breakfast cereal
Number of subjects: 73
Study 21510864 — intervention group
Group type: COMPARATOR
Intervention: Control (no fortification)
Number of subjects: 73
Study 19464535 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (i.d.) vaccination with 3.0 microg HA
Number of subjects: 224
Study 19464535 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (i.d.) vaccination with 4.5 microg HA
Number of subjects: 224
Study 19464535 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (i.d.) vaccination with 6.0 microg HA
Number of subjects: 224
Study 19464535 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (i.m.) vaccination with 15.0 microg HA
Number of subjects: 224
Study 19464535 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (i.d.) vaccination
Number of subjects: 224
Study 19464535 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (i.m.) vaccination
Number of subjects: 224
Study 17207036 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 116
Study 17207036 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 116
Study 15190444 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic assessment of Barrett's esophagus length
Number of subjects: 75
Study 15190444 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological assessment of Barrett's esophagus area from 4QB
Number of subjects: 75
Study 15190444 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between endoscopic and histological assessment
Number of subjects: 75
Study 11689037 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric force contractions with visual feedback
Number of subjects: 48
Study 11689037 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric force contractions without visual feedback
Number of subjects: 48
Study 9424929 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE-1
Number of subjects: 0
Study 7957006 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil plus psyllium fibre (20 g/day)
Number of subjects: 4
Study 7957006 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut oil plus psyllium fibre (20 g/day)
Number of subjects: 4
Study 7957006 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil diet
Number of subjects: 4
Study 7957006 — intervention group
Group type: COMPARATOR
Intervention: Coconut oil diet
Number of subjects: 4
Study 7957006 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium supplementation periods
Number of subjects: 4
Study 3297325 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg p.o.)
Number of subjects: 12
Study 3297325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2122618 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoembolization (CHE)
Number of subjects: 21
Study 2122618 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoembolization (CHE) as initial therapy
Number of subjects: 21
Study 2122618 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoembolization (CHE) with additional portal vein chemotherapy
Number of subjects: 21
Study 49561 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sucrose plus electrolytes as a maintenance solution
Number of subjects: 18
Study 49561 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sucrose plus electrolytes
Number of subjects: 18
Study 49561 — intervention group
Group type: COMPARATOR
Intervention: Oral glucose‐electrolyte solutions
Number of subjects: 18
Study 30869931 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) training with a 4‐hr standardized training and a 4‐week follow‐up coaching sessions
Number of subjects: 347
Study 30869931 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselors in the experimental group
Number of subjects: 347
Study 30869931 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no MI training)
Number of subjects: 347
Study 27507402 — intervention group
Group type: EXPERIMENTAL
Intervention: Teduglutide 0.05 mg/kg/d
Number of subjects: 136
Study 27507402 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotic use
Number of subjects: 136
Study 27507402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 26594277 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom model (asynchronous modules prior to shifts)
Number of subjects: 69
Study 26594277 — intervention group
Group type: COMPARATOR
Intervention: Standard learning method (modules performed at students' discretion)
Number of subjects: 69
Study 26594277 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom model
Number of subjects: 69
Study 23595549 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface electrical stimulation (SES) - motor-level stimulation
Number of subjects: 90
Study 23595549 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface electrical stimulation (SES) - sensory-level stimulation
Number of subjects: 90
Study 23595549 — intervention group
Group type: COMPARATOR
Intervention: Traditional logopedic dysphagia treatment
Number of subjects: 90
Study 21921735 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic Scalpel
Number of subjects: 31
Study 21921735 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 31
Study 19851433 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid sugars (1 sachet, 13 ml, ca. 5.2 g glucose, 5.2 g fructose, 5.2 g sucrose)
Number of subjects: 16
Study 19851433 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose tablet (6 g)
Number of subjects: 16
Study 19851433 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal glucose spray (10 doses, 0.84 g of glucose)
Number of subjects: 16
Study 16830288 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate 2x400 mg, metronidazole 3x500 mg, and tetracycline 2x1000 mg for 14 days (RMT group)
Number of subjects: 82
Study 16830288 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 2x40 mg, bismuth subcitrate 4x300 mg, amoxicillin 2x1000 mg, and clarithromycin 2x500 mg for 14 days (PBAC group)
Number of subjects: 82
Study 15340743 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients undergoing CABG
Number of subjects: 2142
Study 15340743 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic patients undergoing CABG
Number of subjects: 2142
Study 11378663 — intervention group
Group type: EXPERIMENTAL
Intervention: OMC (40 mg omeprazole once a day, 500 mg metronidazole and 250 mg clarithromycin twice daily for 7 days)
Number of subjects: 55
Study 11378663 — intervention group
Group type: COMPARATOR
Intervention: NA (300 mg nizatidine once a day and 1000 mg amoxicillin twice daily for 14 days)
Number of subjects: 55
Study 11378663 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall eradication rate after reallocation
Number of subjects: 55
Study 11378663 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinfection rate after one year
Number of subjects: 55
Study 8996144 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy (HT)
Number of subjects: 410
Study 8996144 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (CT)
Number of subjects: 410
Study 8996144 — intervention group
Group type: EXPERIMENTAL
Intervention: RT plus HT plus CT
Number of subjects: 410
Study 8996144 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 410
Study 8996144 — intervention group
Group type: EXPERIMENTAL
Intervention: RT plus CT
Number of subjects: 410
Study 8996144 — intervention group
Group type: EXPERIMENTAL
Intervention: RT plus HT
Number of subjects: 410
Study 8356858 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with 67% nitrous oxide in oxygen
Number of subjects: 65
Study 8356858 — intervention group
Group type: COMPARATOR
Intervention: Propofol without nitrous oxide (O2)
Number of subjects: 65
Study 2887885 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (10 mg IV every 6 h for 3 days, then 100 mg orally daily for 4 days)
Number of subjects: 114
Study 2887885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 30841030 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 3 mg/kg over 3 min
Number of subjects: 64
Study 30841030 — intervention group
Group type: COMPARATOR
Intervention: No propofol (control group)
Number of subjects: 64
Study 27496209 — intervention group
Group type: EXPERIMENTAL
Intervention: Transaxillary gasless endoscopic thyroidectomy (TGET)
Number of subjects: 33
Study 27496209 — intervention group
Group type: COMPARATOR
Intervention: Conventional open thyroidectomy (COT)
Number of subjects: 33
Study 25660046 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 6
Study 25660046 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 6
Study 25660046 — intervention group
Group type: COMPARATOR
Intervention: Control solution (saline)
Number of subjects: 6
Study 23238118 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program (twice‐weekly training for 12 weeks starting 1 month after hospital discharge)
Number of subjects: 49
Study 23238118 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program
Number of subjects: 49
Study 23238118 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 49
Study 21531773 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention explaining toddler drowning risk and CPR training
Number of subjects: 101
Study 21531773 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 101
Study 21531773 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 101
Study 18097723 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidectomy (PPH group)
Number of subjects: 41
Study 18097723 — intervention group
Group type: COMPARATOR
Intervention: Open hemorrhoidectomy (open group)
Number of subjects: 41
Study 16832714 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (0.5 microg/day)
Number of subjects: 108
Study 16832714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 12960633 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 43
Study 12960633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 10473925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime (2.0 g q. 8 h)
Number of subjects: 45
Study 10473925 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (2.0 g q. 8 h)
Number of subjects: 45
Study 8935482 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sumatriptan 100 mg (second dose)
Number of subjects: 1349
Study 8935482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1349
Study 8935482 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sumatriptan 100 mg (first dose)
Number of subjects: 1349
Study 1930444 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐minute video demonstration of perineal massage
Number of subjects: 83
Study 1930444 — intervention group
Group type: COMPARATOR
Intervention: Routine printed and verbal instruction (Control)
Number of subjects: 83
Study 6352663 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 5
Study 6352663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 28707488 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin (100 μg IV)
Number of subjects: 220
Study 28707488 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin (30 IU IV)
Number of subjects: 220
Study 27855714 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalisation-based treatment (MBT-ED)
Number of subjects: 68
Study 27855714 — intervention group
Group type: COMPARATOR
Intervention: Specialist supportive clinical management (SSCM-ED)
Number of subjects: 68
Study 27855714 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MBT-ED and SSCM-ED)
Number of subjects: 68
Study 24732651 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical decompression of lower extremity nerves
Number of subjects: 42
Study 24732651 — intervention group
Group type: COMPARATOR
Intervention: Control leg (contralateral limb)
Number of subjects: 42
Study 23238499 — intervention group
Group type: EXPERIMENTAL
Intervention: salmon calcitonin 200 IU nasal spray daily + calcium 500 mg
Number of subjects: 60
Study 23238499 — intervention group
Group type: COMPARATOR
Intervention: inactive nasal spray + calcium 500 mg
Number of subjects: 60
Study 20404307 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab (anti-interleukin-1 therapy)
Number of subjects: 13
Study 18307115 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured discussion about the costs of dieting
Number of subjects: 63
Study 18307115 — intervention group
Group type: COMPARATOR
Intervention: Structured discussion about the benefits of dieting
Number of subjects: 63
Study 16491647 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g of glucose
Number of subjects: 0
Study 16491647 — intervention group
Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 0
Study 12215185 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study 9677550 — intervention group
Group type: EXPERIMENTAL
Intervention: latanoprost 0.005%
Number of subjects: 9
Study 10153428 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprinted notes
Number of subjects: 200
Study 10153428 — intervention group
Group type: COMPARATOR
Intervention: Traditional notes
Number of subjects: 200
Study 2240539 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diclofenac sodium
Number of subjects: 160
Study 2240539 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular diclofenac
Number of subjects: 160